<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: plavix</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>FDA extends Plavix patent by 6 months to May 2012</title>
   	 <description>(AP) --  The makers of Plavix, the world's second best-selling medication, said Tuesday they will retain exclusive U.S. marketing rights to the blood thinner for an additional six months, under a decision by U.S. health regulators.</description>
     <link>http://phys.org/news215190857.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 25 Jan 2011 15:15:13 EST</pubDate>
	 <guid isPermaLink="false">news215190857</guid>
	 
</item>
<item>
     <title>Bristol-Myers Squibb sees 3Q profit dip 2 percent</title>
   	 <description>(AP) --  Bristol-Myers Squibb Co. posted a slight decline in third-quarter profit Tuesday as its restrained spending was offset by flat sales of its drugs, lower income from its partners and bigger discounts to government because of the health care overhaul.</description>
     <link>http://phys.org/news207312922.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 26 Oct 2010 12:20:01 EST</pubDate>
	 <guid isPermaLink="false">news207312922</guid>
	 
</item>
<item>
     <title>Study contradicts reports of problems with blood-thinner</title>
   	 <description>New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.</description>
     <link>http://phys.org/news202302875.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 29 Aug 2010 12:15:26 EST</pubDate>
	 <guid isPermaLink="false">news202302875</guid>
	 
</item>
<item>
     <title>Plavix may be treatment for dogs at risk of thromboembolic disease</title>
   	 <description>Companion animals that have a long-term need for anticoagulant drug therapies may soon find help in a top-selling antiplatelet drug marketed to humans:  clopidogrel, commonly known by the trade-name Plavix.</description>
     <link>http://phys.org/news198345749.html</link>
	 <category>Biology</category>
	 <pubDate>Wed, 14 Jul 2010 17:30:01 EST</pubDate>
	 <guid isPermaLink="false">news198345749</guid>
	 
</item>
<item>
     <title>FDA warning: some patients cannot process Plavix</title>
   	 <description>(AP) --  The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.</description>
     <link>http://phys.org/news187628599.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 12 Mar 2010 15:03:46 EST</pubDate>
	 <guid isPermaLink="false">news187628599</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/fdawarningso.jpg" width="90" height="90" />
</item>
<item>
     <title>Drug ads ineffective for boosting sales, could cost taxpayers: study</title>
   	 <description>US Taxpayers may be on the hook for the high cost of drug advertising that does little to boost sales, according to a new study led by a University of British Columbia health policy researcher.</description>
     <link>http://phys.org/news178216980.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 23 Nov 2009 17:20:05 EST</pubDate>
	 <guid isPermaLink="false">news178216980</guid>
	 
</item>
<item>
     <title>FDA says heartburn drugs can interfere with Plavix</title>
   	 <description>(AP) --  Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.</description>
     <link>http://phys.org/news177687676.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Nov 2009 13:50:18 EST</pubDate>
	 <guid isPermaLink="false">news177687676</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/fdasaysheart.jpg" width="90" height="135" />
</item>
<item>
     <title> New Anti-Clotting Medication Not More Effective than Standard Care; Hint of Other Clinical Benefits </title>
   	 <description>(PhysOrg.com) -- Two large studies confirmed that an investigational, reversible anti-clotting medication failed to show greater effectiveness than clopidogrel or a placebo for patients undergoing a procedure to open blocked coronary arteries, according to researchers at the Duke Clinical Research Institute.</description>
     <link>http://phys.org/news177679625.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Nov 2009 11:40:03 EST</pubDate>
	 <guid isPermaLink="false">news177679625</guid>
	 
</item>
<item>
     <title>Medco plans to compare Plavix, Effient in study</title>
   	 <description>(AP) --  Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world's second-best selling drug, with the newer Effient.</description>
     <link>http://phys.org/news175268747.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 20 Oct 2009 15:30:01 EST</pubDate>
	 <guid isPermaLink="false">news175268747</guid>
	 
</item>
<item>
     <title>Newer Anti-Clotting Medication Found to Be More Effective</title>
   	 <description>(PhysOrg.com) -- A large head-to-head study of two anti-clotting medications for heart patients has found that the investigational compound ticagrelor (Brilinta) was more effective at reducing cardiovascular death than the current standard of care, clopidogrel (Plavix), according to researchers at Duke University Medical Center. </description>
     <link>http://phys.org/news170863591.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 30 Aug 2009 15:11:03 EST</pubDate>
	 <guid isPermaLink="false">news170863591</guid>
	 
</item>
<item>
     <title>Study shows experimental drug cuts stroke risk</title>
   	 <description>(AP) --  An experimental drug reduces the stroke risk in patients with irregular heartbeats by more than three times, compared with the popular drug warfarin - but possibly at a cost, according to new research released Sunday.</description>
     <link>http://phys.org/news170833009.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 30 Aug 2009 06:37:40 EST</pubDate>
	 <guid isPermaLink="false">news170833009</guid>
	 
</item>
<item>
     <title>Researchers identify gene variant linked to effectiveness of plavix</title>
   	 <description>Researchers at the University of Maryland School of Medicine have identified a common gene variant carried by as many as a third of the general population that is believed to play a major role in determining why people do not respond to a popular anti-clotting medication, Plavix. If the medication doesn't work, patients are at increased risk for subsequent heart attacks, strokes and other serious cardiovascular problems.</description>
     <link>http://phys.org/news170436030.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 25 Aug 2009 16:21:50 EST</pubDate>
	 <guid isPermaLink="false">news170436030</guid>
	 
</item>
<item>
     <title>FDA clears Eli Lilly's blood thinner Effient</title>
   	 <description>(AP) --  The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.</description>
     <link>http://phys.org/news166470860.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 10 Jul 2009 19:10:01 EST</pubDate>
	 <guid isPermaLink="false">news166470860</guid>
	 
</item>
<item>
     <title>How life-threatening blood clots take hold</title>
   	 <description>When plaques coating blood vessel walls rupture and expose collagen, platelets spring into action to form a blood clot at the damaged site. Now, a new report in the April 17th issue of the journal Cell, a Cell Press publication, reveals how those life-threatening clots—a leading cause of death in the United States, Europe and other industrialized countries--get an early grip. The discovery might offer a new way to fight clot formation before it can even begin, according to the researchers.</description>
     <link>http://phys.org/news159105219.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 16 Apr 2009 12:54:10 EST</pubDate>
	 <guid isPermaLink="false">news159105219</guid>
	 
</item>
<item>
     <title>Study: Plavix plus aspirin helps prevent strokes</title>
   	 <description>(AP) --  Taking the blood thinner Plavix along with aspirin helped prevent strokes and heart attacks in people with a common heartbeat abnormality that puts them at high risk of these problems, doctors reported Tuesday.</description>
     <link>http://phys.org/news157716473.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 31 Mar 2009 11:08:23 EST</pubDate>
	 <guid isPermaLink="false">news157716473</guid>
	 
</item>


</channel>
</rss>
